Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CANB

Can B (CANB) Stock Price, News & Analysis

Can B logo

About Can B Stock (NASDAQ:CANB)

Advanced Chart

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.37
$8.24
52-Week Range
$0.27
$1.05
Volume
275,663 shs
Average Volume
189,959 shs
Market Capitalization
$1.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Can B Corp. engages in the development, production, and sale of products and delivery devices containing cannabidiol. Its product portfolio includes hemp extract oils and sprays, pain and skin care, softgels and capsules, superfoods, supplements, bath and spa, and pets. The company was founded by Rolv Eitrem Heggenhougen and Romuald Stone on October 11, 2005 and is headquartered in Hicksville, NY.

Receive CANB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Can B and its competitors with MarketBeat's FREE daily newsletter.

CANB Stock News Headlines

Trump’s worst nightmare
The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washington… even Trump’s obsession with seizing Greenland. There’s a singular force that connects the dots… And it could threaten to transform American life – and your wealth – forever.
See More Headlines

CANB Stock Analysis - Frequently Asked Questions

Can B (CANB) raised $10 million in an initial public offering on Tuesday, August 9th 2022. The company issued 2,000,000 shares at a price of $5.05 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Can B investors own include Fulcrum Therapeutics (FULC), Actinium Pharmaceuticals (ATNM), Provention Bio (PRVB), VIVUS (VVUS), Chimerix (CMRX), OpGen (OPGN) and Processa Pharmaceuticals (PCSA).

Company Calendar

Today
6/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:CANB
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.74 million
Net Margins
-1,238.33%
Pretax Margin
-1,351.68%

Debt

Sales & Book Value

Annual Sales
$2.16 million
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-0.07

Miscellaneous

Free Float
74,137,000
Market Cap
$1.63 million
Optionable
Not Optionable
Beta
1.46
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:CANB) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners